FIELD: medicine; cardiology.
SUBSTANCE: transthoracic echocardiography is performed, the level of blood pressure is measured according to the Korotkov’s method. Based on these data, as well as indicators of global longitudinal deformation the value of the global constructive work of the LV myocardium (GCW) is determined. With a GCW value <762 mmHg, %, in patients with chronic heart failure with reduced left ventricular ejection fraction and atrial fibrillation a high risk of adverse cardiovascular events during the next 12 months of follow-up after implantation of the cardiac contractility modulation system is predicted.
EFFECT: method provides improved accuracy of predicting adverse cardiovascular events.
1 cl, 3 dwg, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING POSITIVE RESPONSE TO CARDIAC CONTRACTILITY MODULATION THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION AND ATRIAL FIBRILLATION | 2023 |
|
RU2807230C1 |
METHOD FOR PREDICTING IMPROVEMENT IN MYOCARDIAL CONTRACTILITY IN PATIENTS WITH CHRONIC HEART FAILURE AGAINST BACKGROUND OF MODULATION OF CARDIAC CONTRACTILITY | 2023 |
|
RU2806976C1 |
METHOD FOR PREDICTING THE ONE-YEAR RISK OF ADVERSE CARDIOVASCULAR EVENTS IN MEN AFTER DECOMPENSATION OF CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION AND OBSTRUCTIVE SLEEP APNEA SYNDROME | 2021 |
|
RU2767266C1 |
METHOD FOR DETERMINING SITE FOR IMPLANTATION OF VENTRICULAR ELECTRODES OF CARDIAC CONTRACTILITY MODULATION DEVICE IN PATIENTS WITH CHRONIC HEART FAILURE | 2022 |
|
RU2806973C1 |
METHOD FOR PREDICTION OF REMOTE UNFAVORABLE OUTCOMES IN PATIENTS WITH HEART FAILURE AND IMPLANTED CARDIOVERTER-DEFIBRILLATOR | 2023 |
|
RU2819279C1 |
METHOD OF PREDICTING RISK OF DEVELOPING ACUTE DECOMPENSATION OF HEART FAILURE IN PATIENTS WITH LOW LEFT VENTRICULAR EJECTION FRACTION AND IMPLANTED CARDIOVERTER-DEFIBRILLATOR | 2023 |
|
RU2809775C1 |
METHOD FOR PREDICTING RISK OF DEVELOPING NONARRHYTHMIC DEATH IN FOUR-YEAR FOLLOW-UP PERIOD IN PATIENTS WITH HEART FAILURE WITH REDUCED LEFT VENTRICULAR FRACTION AND AN IMPLANTED CARDIOVERTER-DEFIBRILLATOR | 2023 |
|
RU2820923C1 |
METHOD FOR INDIVIDUAL SELECTION OF SUPPORTING DOSE OF LEVOSIMENDAN FOR TREATING ACUTE HEART FAILURE IN ELDERLY PATIENTS IN ACUTE PHASE OF MYOCARDIAL INFARCTION | 2015 |
|
RU2601666C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH ACUTE DECOMPENSATION OF ISCHEMIC CHRONIC HEART FAILURE WITH SYSTOLIC DYSFUNCTION OF THE LEFT VENTRICLE OF THE HEART AFTER COMPLETE MYOCARDIAL REVASCULARIZATION | 2021 |
|
RU2770271C1 |
METHOD FOR PREDICTING THE RISK OF PROGRESSING CHRONIC HEART FAILURE IN PATIENTS WITH MYOCARDIAL INFARCTION | 2019 |
|
RU2734671C1 |
Authors
Dates
2023-10-02—Published
2023-02-07—Filed